Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.
Wistuba II, Behrens C, Lombardi F, Wagner S, Fujimoto J, Raso MG, Spaggiari L, Galetta D, Riley R, Hughes E, Reid J, Sangale Z, Swisher SG, Kalhor N, Moran CA, Gutin A, Lanchbury JS, Barberis M, Kim ES.
Wistuba II, et al. Among authors: lanchbury js.
Clin Cancer Res. 2013 Nov 15;19(22):6261-71. doi: 10.1158/1078-0432.CCR-13-0596. Epub 2013 Sep 18.
Clin Cancer Res. 2013.
PMID: 24048333
Free PMC article.